XML 30 R17.htm IDEA: XBRL DOCUMENT
v3.23.1

Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2022
Income Tax Disclosure [Abstract] |
Income Taxes | Income Taxes The provision for income taxes consists of the following (in thousands):
|  | Year Ended December 31,
|  | 2022 |  | 2021
Current: |  |  |  |
Federal |  | $ | — |  |  | $ | — |
State |  | 24 |  |  | 27 |
Total current |  | 24 |  |  | 27 |
Deferred: |  |  |  |
Federal |  | (137) |  |  | 137 |
State |  | (169) |  |  | 11 |
Total deferred |  | (306) |  |  | 148 |
Provision (benefit) for income tax |  | $ | (282) |  |  | $ | 175 |
The effective tax rate of our provision for income taxes differs from the federal statutory rate as follows:
|  | Year Ended December 31,
|  | 2022 |  | 2021
Federal statutory tax rate |  | (21.0) | % |  | (21.0) | %
State income taxes, net of federal tax benefits |  | (4.3) | % |  | (3.8) | %
Research and development tax credits |  | (1.5) | % |  | (1.2) | %
Stock compensation |  | 1.4 | % |  | 0.9 | %
Non-deductible expenses |  | 0.9 | % |  | 1.1 | %
Change in valuation allowance |  | 23.9 | % |  | 24.6 | %
Effective tax rate |  | (0.6) | % |  | 0.6 | %
Significant components of the Company’s deferred tax assets at December 31, 2022 and 2021 are shown below (in thousands). A valuation allowance has been established as realization of the Company’s deferred tax assets has not met the more likely-than-not threshold requirement. If the Company’s judgment changes and it is determined that the Company will be able to realize these deferred tax assets, the tax benefits relating to any reversal of the valuation allowance on deferred tax assets will be accounted for as a reduction to income tax expense.
|  | December 31,
|  | 2022 |  | 2021
Deferred tax assets: |  |  |  |
Net operating loss carryforwards |  | $ | 29,789 |  |  | $ | 22,365 |
Research and development tax credits |  | 2,216 |  |  | 1,102 |
Accruals, reserves and other |  | 349 |  |  | 1,055 |
Interest expense |  | 2,236 |  |  | 1,953 |
Indefinite lived assets |  | 362 |  |  | — |
Stock compensation |  | 1,606 |  |  | 1,407 |
Lease liability |  | 1,374 |  |  | — |
Capitalization of research and experimentation costs |  | 2,047 |  |  | — |
Total gross deferred tax assets |  | 39,979 |  |  | 27,882 |
Less: valuation allowance |  | (38,567) |  |  | (27,158) |
Deferred tax assets, net |  | 1,412 |  |  | 724 |
Deferred tax liabilities: |  |  |  |
Financing and acquisition-related liabilities |  | — |  |  | (335) |
Indefinite lived assets |  | — |  |  | (521) |
Right of use assets |  | (1,206) |  |  | — |
Basis differences in fixed and intangible assets |  | (206) |  |  | (175) |
Deferred tax liabilities, net |  | (1,412) |  |  | (1,031) |
Net deferred tax liabilities |  | $ | — |  |  | $ | (307) |
Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2022 and 2021, which related primarily to increases in net operating loss (NOL) carryforwards, research and development tax credits, capitalization of research and experimentation costs, and impairment of goodwill were as follows (in thousands):
|  | December 31,
|  | 2022 |  | 2021
Valuation allowance at the beginning of the year |  | $ | 27,158 |  |  | $ | 20,596 |
Increases recorded to income tax provision |  | 11,409 |  |  | 6,562 |
Valuation allowance at the end of the year |  | $ | 38,567 |  |  | $ | 27,158 |
At December 31, 2022 and 2021, the Company had federal NOL carryforwards of approximately $118.4 million and $89.4 million, respectively. At December 31, 2022 and 2021, the Company had state NOL carryforwards of $87.0 million and $61.0 million, respectively. Approximately $43.5 million of the federal tax loss carryforwards will begin to expire in 2023, unless previously utilized. The federal NOL carryforwards generated in after December 31, 2017 of $74.9 million will carryforward indefinitely. The Company’s state tax loss carryforwards will expire in 2030, unless previously utilized. At December 31, 2022, the Company's deferred tax assets are primarily comprised of federal and state tax NOL carryforwards. The Company completed a formal study through the year ended December 31, 2019 and determined ownership changes within the meaning of Internal Revenue Code (IRC), Section 382 had occurred in 2003, 2008, 2012, 2017 and 2019. The Company is subject to taxation in the United States and in various state jurisdictions. The Company’s tax years for 2003 and forward are subject to examination by the U.S. and state tax authorities due to the carryforward of unutilized net operating losses and research and development credits. The Company recognizes interest and/or penalties related to income tax matters in its provision for income taxes. The Company does not have any material accruals for, and did not recognize any, material interest or penalties in these financial statements in any period presented. Uncertain Tax Positions At December 31, 2022 and 2021, the Company had no unrecognized tax benefits. The Company does not believe that the balance of unrecognized tax benefits will materially change within the next twelve months.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 17 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 14 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 270 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -URI https://asc.fasb.org/topic&trid=2144680 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration